Serum biomarkers of bone metabolism in castration-resistant prostate cancer patients with skeletal metastases: results from SWOG 0421. - Wikidata - wikimedia - TriplyDB

Serum biomarkers of bone metabolism in castration-resistant prostate cancer patients with skeletal metastases: results from SWOG 0421.

Serum biomarkers of bone metabolism in castration-resistant prostate cancer patients with skeletal metastases: results from SWOG 0421.

http://www.wikidata.org/entity/Q37696687

about

Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: a phase III metastatic castration resistant prostate cancer trial.2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications The best of both worlds - managing the cancer, saving the bone.Biomarkers for the Management of Castration-Resistant Prostate Cancer: We Are Not There Yet.Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone Metastases.The value of biomarkers in bone metastasis.The role of biomarkers in the management of bone-homing malignancies.Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio.A mini-review of quality of life as an outcome in prostate cancer trials: patient-centered approaches are needed to propose appropriate treatments on behalf of patients.Q58736053

P2860

Q27334654-11253AEB-C6BC-41B2-BB22-A9AE789E80A0 Q30239808-1BC1DEE3-F6E4-44DC-8662-6FA9AE4A9ACD Q33920055-B85C361B-08A3-4D78-B37D-EC103A053960 Q36407003-12C8FF6A-5DBB-4178-B083-0FF237597FF5 Q38700342-01B3E755-B89E-4619-ABDE-A6447B3175B5 Q39400189-09DDA9EB-E778-4AA1-9D5A-132BE44400CE Q41692580-800BA2A9-0992-4659-B836-E1FA1CF4349B Q53036812-FF0CF383-99DC-455D-A1ED-4779BF39B8A5 Q55252859-EFC46008-29A9-45EB-94DE-C5ADE12604CE Q58736053-E80D8764-88A0-4F90-B497-28C1496F483B

P2860

Serum biomarkers of bone metabolism in castration-resistant prostate cancer patients with skeletal metastases: results from SWOG 0421.

http://www.wikidata.org/entity/Q37696687

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serum biomarkers of bone metab ...... tases: results from SWOG 0421.

@en

Serum biomarkers of bone metab ...... tases: results from SWOG 0421.

@nl

type

label

Serum biomarkers of bone metab ...... tases: results from SWOG 0421.

@en

Serum biomarkers of bone metab ...... tases: results from SWOG 0421.

@nl

prefLabel

Serum biomarkers of bone metab ...... tases: results from SWOG 0421.

@en

Serum biomarkers of bone metab ...... tases: results from SWOG 0421.

@nl

P1433

Q37696687-189BEFC2-96C4-4CF3-97AC-7051934102DE

P1476

Q37696687-69CD9D24-542A-405C-8DB2-27857AB1EEBB

P2093

Q37696687-0E2009BA-5134-4F84-90F7-537300981CF1

Q37696687-1C74C81E-B76B-4929-B763-37C628D801AC

Q37696687-1E97CEFC-6384-4B5C-9882-2A49B2E915F1

Q37696687-41A3366E-FAC4-4B60-B438-B4D4491DF8B9

Q37696687-43C62AF5-ED3D-4A68-B984-BDD32981FF30

Q37696687-5670FD50-1B4F-4388-B618-021B6516452F

Q37696687-5D6F47BB-CC56-42F5-8534-C967E7A73BFF

Q37696687-88220AFB-D4FA-4D04-8B44-A8885AE981A5

Q37696687-93DFD0B6-40D0-4A28-B98C-4A3B6CA03876

Q37696687-A830B547-D6B7-4697-8D65-335FCBCF9590

P2860

Q37696687-07F29FDC-E8CD-4D12-B00F-38DF10534AD5

Q37696687-11EE6930-7F33-4849-AB38-2C2EF8F6F692

Q37696687-1589938C-46A0-4A0C-A2D3-F8AE2FF1EC72

Q37696687-2B5D833A-7B33-4C58-ABFB-55597603B634

Q37696687-2E78EB36-4536-40E9-9103-409DFE278DFD

Q37696687-30FE7055-C4C4-4F67-8E21-48F1882D1EE3

Q37696687-49159C16-174C-4DB5-9AF1-0A53BB210E44

Q37696687-4EA4D5CD-02E3-4AEA-AC7A-8FC92F2A318F

Q37696687-54AF9C36-1547-4C36-B22E-E8FF07267478

Q37696687-5E6E6A7E-DC82-463C-BF4E-0B69955931F5

P304

Q37696687-561639EC-0FB0-4218-8E4B-EB31FD2F481F

P31

Q37696687-67C6EB5E-E8A9-410A-B4CF-586763D20CDE

P356

Q37696687-0C15E3BB-276A-4DE3-899E-B2976C7DBF70

P407

Q37696687-4565159E-3A8E-4265-B415-24469C756332

P433

Q37696687-FA485932-F0EC-4887-B214-F30BBCC89904

P478

Q37696687-49541540-1856-45BD-B07D-E53380E030E9

P50

Q37696687-3DDB1775-3BED-438F-B3E7-EB9F09D2DC39

P577

Q37696687-CD7E470F-622F-4B46-8831-AF59F44B49F8

P5875

Q37696687-EFF1F937-2E9E-4CFE-A805-64A68E205EB2

P698

Q37696687-6175A1A0-7F04-410E-94B6-1161E8DA948A

P921

Q37696687-D8C12C25-CE83-4895-B6BC-D13E560EC477

P932

Q37696687-432AE3B0-0E38-4BED-B48F-B32A2FC2D375

P356

P1433

Journal of the National Cancer Institute

P1476

Serum biomarkers of bone metab ...... tases: results from SWOG 0421.

@en

P2093

Amir Goldkorn

http://www.w3.org/2001/XMLSchema#string

Benjamin Ely

http://www.w3.org/2001/XMLSchema#string

Catherine Tangen

http://www.w3.org/2001/XMLSchema#string

Erik Gertz

http://www.w3.org/2001/XMLSchema#string

Ian M Thompson

http://www.w3.org/2001/XMLSchema#string

Maha Hussain

http://www.w3.org/2001/XMLSchema#string

Marta D Van Loan

http://www.w3.org/2001/XMLSchema#string

Nicholas J Vogelzang

http://www.w3.org/2001/XMLSchema#string

Philip C Mack

http://www.w3.org/2001/XMLSchema#string

Primo N Lara

http://www.w3.org/2001/XMLSchema#string

P2860

The endothelin axis: emerging role in cancer

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial

Time-dependent ROC curves for censored survival data and a diagnostic marker.

Endothelium-derived factors as paracrine mediators of prostate cancer progression.

Markers of bone turnover in bone metastases.

Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer.

Endothelin-1 and osteoblastic metastasis

A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases.

Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma.

Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension.

P304

dju013

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJU013

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260377897

http://www.w3.org/2001/XMLSchema#string

P698

24565955

http://www.w3.org/2001/XMLSchema#string

P921

P932

3982883

http://www.w3.org/2001/XMLSchema#string